KALETRA Side Effects

7023426-9 | Bone Marrow Failure, Rash
on Sep 22, 2010 Male patient from FRANCE , 36 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, rash (What is rash?). Kaletra dosage: . During the same period patient was treated with VINBLASTINE (View Vinblastine Review and Vinblastine Label ). Patient was hospitalized.

7019294-1 | Abortion Induced
Patient was taking Kaletra (View Usage). Patient had the following side effects: abortion induced on Sep 22, 2010 from THAILAND Additional patient health information: Female patient , 17 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Kaletra dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), COMBIVIR (600/300mg Daily) (View Combivir Review and Combivir Label ), VIREAD (View Viread Review and Viread Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ).

7019193-5 | Abortion Induced
Adverse event was reported on Sep 23, 2010 by a Female patient taking Kaletra (View Usage) (Dosage: 400/200 Mg/day) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 17 years of age, After Kaletra was administered, patient had the following side effects: abortion induced. During the same period patient was treated with LAMIVUDINE (300 Mg/day) (View Lamivudine Review and Lamivudine Label ), ABACAVIR (600 Mg/day) (View Abacavir Review and Abacavir Label ), ETRAVIRINE (400 Mg/day) (View Etravirine Review and Etravirine Label ).

7018260-X | Anal Cancer, Anogenital Warts, Bronchitis, Leukopenia, Squamous Cell Carcinoma, Thrombocytopenia
on Sep 21, 2010 Male patient from GERMANY , weighting 163.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: anal cancer (What is anal cancer?), anogenital warts, bronchitis (What is bronchitis?), leukopenia, squamous cell carcinoma, thrombocytopenia. Kaletra dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.


7013858-7 | Guillain-barre Syndrome
on Sep 24, 2010 Male patient from UNITED STATES , weighting 232.2 lb, was diagnosed with hiv test positive (What is hiv test positive?) and was treated with Kaletra (View Usage). Patient had the following side effects: guillain-barre syndrome (What is guillain-barre syndrome?). Kaletra dosage: . Patient was hospitalized.

7013854-X | Dysarthria
Patient was taking Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: dysarthria on Sep 16, 2010 from SWITZERLAND Additional patient health information: Male patient , 51 years of age, was diagnosed with hiv infection cdc group iii (What is hiv infection cdc group iii?) and. Kaletra dosage: 50/200mg, 3 Tabs In Am, 2 Tabs In Pm. During the same period patient was treated with INTELENCE (View Intelence Review and Intelence Label ), ISENTRESS (View Isentress Review and Isentress Label ). Patient was hospitalized.

7007634-9 | Rhabdomyolysis
Adverse event was reported on Sep 15, 2010 by a Female patient taking Kaletra (View Usage) (Dosage: Not Reported) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 32 years of age, Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. During the same period patient was treated with EMTRICITABINE W/TENOFOVIR (Not Reported) (View Emtricitabine W/tenofovir Review and Emtricitabine W/tenofovir Label ).

7007034-1 | Sick Sinus Syndrome
on Sep 13, 2010 Male patient from UNITED STATES , 52 years of age, was treated with Kaletra (View Usage). Patient had the following side effects: sick sinus syndrome. Kaletra dosage: .

7006012-6 | Ocular Hypertension
on Sep 14, 2010 Male patient from , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: ocular hypertension. Kaletra dosage: 200mg/50mg (4dosage Forms Daily). During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ).

7005490-6 | Guillain-barre Syndrome
Patient was taking Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: guillain-barre syndrome (What is guillain-barre syndrome?) on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 232.2 lb, was diagnosed with hiv test positive (What is hiv test positive?) and. Kaletra dosage: . Patient was hospitalized.

7003255-2 | Fall, Gait Disturbance, Rhabdomyolysis
Adverse event was reported on Sep 13, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: ) was diagnosed with prophylaxis against hiv infection (What is prophylaxis against hiv infection?) and. Location: FRANCE , 69 years of age, Patient had the following side effects: fall (What is fall?), gait disturbance, rhabdomyolysis. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), EZETIMIBE/SIMVASTATIN (View Ezetimibe/simvastatin Review and Ezetimibe/simvastatin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CANDESARTAN CILEXETIL/HYDROCHLOROTHIAZIDE (ATACAND HCT) (View Candesartan Cilexetil/hydrochlorothiazide (atacand Hct) Review and Candesartan Cilexetil/hydrochlorothiazide (atacand Hct) Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

7002605-0 | Abortion Induced
on Sep 10, 2010 Female patient from UNITED STATES , 36 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: abortion induced. Kaletra dosage: 1000 Mg/day. During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ).

6992325-0 | Abortion Induced
on Sep 07, 2010 Female patient from UNITED STATES , 18 years of age, was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced. Kaletra dosage: 800/200 Mg/day, 4 Tab/caps Daily. During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (600/) (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ).

6989705-6 | Coma Hepatic, Hepatic Cirrhosis, Hepatic Failure, Hiv Infection
Patient was taking Kaletra (View Usage). Patient had the following side effects: coma hepatic, hepatic cirrhosis, hepatic failure, hiv infection (What is hiv infection?) on Sep 07, 2010 from THAILAND Additional patient health information: Female patient , weighting 95.68 lb, was diagnosed with hiv infection (What is hiv infection?) and. Kaletra dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), TRIAMCINOLONE (View Triamcinolone Review and Triamcinolone Label ), PHENYL CYCLOHEXYL PIPERIDINE (View Phenyl Cyclohexyl Piperidine Review and Phenyl Cyclohexyl Piperidine Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ).

6979415-3 | Anger, Anxiety, Asthenia, Back Pain, Burnout Syndrome, Cognitive Disorder, Confusional State, Cough, Dental Caries
Adverse event was reported on Sep 07, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: 800/200 Mg X2 Every 12 Hour) was diagnosed with prophylaxis, gastroduodenitis, pharyngitis and. Location: MEXICO , weighting 172.0 lb, After Kaletra was administered, patient had the following side effects: anger, anxiety (What is anxiety?), asthenia, back pain (What is back pain?), burnout syndrome, cognitive disorder, confusional state, cough, dental caries. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PARACETAMOL + CAFFEINE (View Paracetamol + Caffeine Review and Paracetamol + Caffeine Label ), AFRIN (View Afrin Review and Afrin Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized and became disabled.

6977406-X | Dysarthria
on Aug 31, 2010 Male patient from SWITZERLAND , 51 years of age, was diagnosed with hiv infection cdc group iii (What is hiv infection cdc group iii?) and was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: dysarthria. Kaletra dosage: 50/200mg, 3 Tabs In Am, 2 Tabs In Pm. During the same period patient was treated with INTELENCE (Long Term) (View Intelence Review and Intelence Label ), ISENTRESS (View Isentress Review and Isentress Label ). Patient was hospitalized.

6974146-8 | Demyelinating Polyneuropathy, Muscle Spasms, Pain In Extremity, Paraesthesia
on Aug 31, 2010 Male patient from GERMANY , 33 years of age, was diagnosed with hiv infection (What is hiv infection?), hypertension, prophylaxis and was treated with Kaletra (View Usage). Patient had the following side effects: demyelinating polyneuropathy, muscle spasms, pain in extremity, paraesthesia. Kaletra dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RETROVIR (View Retrovir Review and Retrovir Label ), SALUTEC (View Salutec Review and Salutec Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

6973893-1 | Escherichia Urinary Tract Infection, Pyelonephritis Acute
Patient was taking Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: escherichia urinary tract infection, pyelonephritis acute on Aug 30, 2010 from SPAIN Additional patient health information: Male patient , weighting 111.8 lb, was diagnosed with hiv infection (What is hiv infection?), lipoatrophy and. Kaletra dosage: . Patient was hospitalized.

6971744-2 | Anogenital Warts
Adverse event was reported on Aug 30, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: 800mg/200mg) was diagnosed with hiv infection (What is hiv infection?) and. Location: GERMANY , weighting 194.0 lb, Patient experienced the following unwanted or unexpected effects: anogenital warts. During the same period patient was treated with TRUVADA (200mg/245mg) (View Truvada Review and Truvada Label ). Patient was hospitalized.

6969306-6 | Abortion Induced
on Sep 03, 2010 Female patient from UNITED STATES , 18 years of age, was treated with Kaletra (View Usage). Patient had the following side effects: abortion induced. Kaletra dosage: 800/200 Mg/day, 4 Tab/caps Daily. During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (600/) (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ).

6968905-5 | Abortion Induced
on Sep 02, 2010 Female patient from UNITED STATES , 18 years of age, was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: abortion induced. Kaletra dosage: 800/200 Mg/day. During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (600/) (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ).

6966422-X | Agranulocytosis, Anaemia, Breast Cancer, Dyspnoea, Leukopenia, Metastases To Bone, Metastases To Spine, Neuropathy Peripheral
Patient was taking Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, anaemia, breast cancer (What is breast cancer?), dyspnoea, leukopenia, metastases to bone, metastases to spine, neuropathy peripheral on Sep 05, 2010 from FRANCE Additional patient health information: Female patient , 50 years of age, was diagnosed with hiv infection (What is hiv infection?), metastasis and. Kaletra dosage: . During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ), TRUVADA (View Truvada Review and Truvada Label ), HERCEPTINE (View Herceptine Review and Herceptine Label ). Patient was hospitalized.

6965982-2 | Ectopic Pregnancy
Adverse event was reported on Aug 31, 2010 by a Female patient taking Kaletra (View Usage) (Dosage: 4 Tablets Daily) was diagnosed with antiviral treatment and. Location: UNITED STATES , 31 years of age, Patient had the following side effects: ectopic pregnancy. During the same period patient was treated with COMBIVIR (2 Tablets Daily) (View Combivir Review and Combivir Label ).

6962530-8 | Bronchitis, C-reactive Protein Increased
on Aug 27, 2010 Male patient from JAPAN , weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?), rhinitis allergic and was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: bronchitis (What is bronchitis?), c-reactive protein increased. Kaletra dosage: 4 Dosage Forms Daily. During the same period patient was treated with COMBIVIR (2 Dosage Forms Daily) (View Combivir Review and Combivir Label ), TENOFOVIR (300mg Daily) (View Tenofovir Review and Tenofovir Label ), OLOPATADINE HYDROCHLORIDE (View Olopatadine Hydrochloride Review and Olopatadine Hydrochloride Label ). Patient was hospitalized.

6956760-9 | Progressive Multifocal Leukoencephalopathy
on Aug 25, 2010 Male patient from JAPAN , 42 years of age, was diagnosed with hiv infection (What is hiv infection?), opportunistic infection prophylaxis, mycobacterium avium complex infection and was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: progressive multifocal leukoencephalopathy. Kaletra dosage: 4 Tablets Daily. During the same period patient was treated with EPZICOM (1 Tablet Daily) (View Epzicom Review and Epzicom Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), RIFABUTIN (View Rifabutin Review and Rifabutin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

6956695-1 | Agranulocytosis, Anaemia, Breast Cancer, Dyspnoea, Metastases To Bone, Metastases To Spine, Neuropathy Peripheral, Neutropenia
Patient was taking Kaletra (View Usage). Patient had the following side effects: agranulocytosis, anaemia, breast cancer (What is breast cancer?), dyspnoea, metastases to bone, metastases to spine, neuropathy peripheral, neutropenia on Aug 20, 2010 from FRANCE Additional patient health information: Female patient , 50 years of age, was diagnosed with hiv infection (What is hiv infection?), metastasis and. Kaletra dosage: . During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ), TRUVADA (View Truvada Review and Truvada Label ), HERCEPTINE (View Herceptine Review and Herceptine Label ). Patient was hospitalized.

6943338-6 | Pre-eclampsia, Premature Labour
Adverse event was reported on Aug 17, 2010 by a Female patient taking Kaletra (View Usage) (Dosage: Tabs/caps) . Location: UNITED STATES , 33 years of age, After Kaletra was administered, patient had the following side effects: pre-eclampsia, premature labour. During the same period patient was treated with LEXIVA (View Lexiva Review and Lexiva Label ), COMBIVIR (Tabs/caps) (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (Tabs/caps) (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

6942898-9 | Jaundice Neonatal
on Aug 16, 2010 Male patient from UNITED STATES , weighting 6.31 lb, was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice neonatal. Kaletra dosage: . During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ).

6942492-X | Apnoea, Bradycardia, Congenital Anaemia, Premature Baby
on Aug 16, 2010 Female patient from UNITED STATES , weighting 5.58 lb, was treated with Kaletra (View Usage). Patient had the following side effects: apnoea, bradycardia, congenital anaemia, premature baby. Kaletra dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ). Patient was hospitalized.

6936887-8 | Gastroschisis, Premature Baby
Patient was taking Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: gastroschisis, premature baby on Aug 13, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 4.70 lb, . Kaletra dosage: . During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ).

6934642-6 | Diarrhoea, Hepatic Cirrhosis, Hepatic Enzyme Increased
Adverse event was reported on Aug 13, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: 2x2) was diagnosed with hiv infection (What is hiv infection?) and. Location: GERMANY , weighting 200.6 lb, Patient experienced the following unwanted or unexpected effects: diarrhoea, hepatic cirrhosis, hepatic enzyme increased. During the same period patient was treated with TRUVADA (1x1) (View Truvada Review and Truvada Label ), KVX (View Kvx Review and Kvx Label ).

6934520-2 | Atrioventricular Block Complete, Cardiomyopathy, Premature Baby
on Aug 12, 2010 Female patient from NETHERLANDS , weighting 2.18 lb, was diagnosed with prophylaxis against hiv infection (What is prophylaxis against hiv infection?) and was treated with Kaletra (View Usage). Patient had the following side effects: atrioventricular block complete, cardiomyopathy (What is cardiomyopathy?), premature baby. Kaletra dosage: 460/115 Mg/m**2 Per Day. During the same period patient was treated with LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6932311-X | Coarctation Of The Aorta
on Aug 06, 2010 Male patient from , weighting 7.50 lb, was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: coarctation of the aorta. Kaletra dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6931284-3 | Aplastic Anaemia, Eye Disorder
Patient was taking Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: aplastic anaemia, eye disorder on Aug 04, 2010 from GERMANY Additional patient health information: Male patient , weighting 149.9 lb, was diagnosed with hiv infection (What is hiv infection?), antifungal prophylaxis, depression (What is depression?), alcohol abuse and. Kaletra dosage: 200/50 2x2 Per Day. During the same period patient was treated with TRUVADA (200/245) (View Truvada Review and Truvada Label ), COTRIM (View Cotrim Review and Cotrim Label ), ISENTRESS (View Isentress Review and Isentress Label ), ABACAVIR SULFATE AND LAMIVUDINE (View Abacavir Sulfate And Lamivudine Review and Abacavir Sulfate And Lamivudine Label ), PSYCHOTROPICS (View Psychotropics Review and Psychotropics Label ).

6931248-X | Abdominal Pain, Affect Lability, Aggression, Asthenia, Body Temperature Increased, Cerebral Atrophy, Cerebral Ventricle Dilatation, Cognitive Disorder, Computerised Tomogram Abnormal
Adverse event was reported on Aug 04, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: 2x2 Per Os) was diagnosed with hiv infection (What is hiv infection?) and. Location: GERMANY , weighting 123.5 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), affect lability, aggression, asthenia, body temperature increased, cerebral atrophy, cerebral ventricle dilatation, cognitive disorder, computerised tomogram abnormal. During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ), MIRTAZEPAM (View Mirtazepam Review and Mirtazepam Label ), DELIX (Pause) (View Delix Review and Delix Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FERRONASOL DUODENAL (View Ferronasol Duodenal Review and Ferronasol Duodenal Label ). Patient was hospitalized.

6930840-6 | Stillbirth
on Aug 17, 2010 Female patient from UNITED STATES , 26 years of age, was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: stillbirth. Kaletra dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6929229-5 | Iron Deficiency Anaemia, Oligohydramnios, Postpartum Haemorrhage, Pre-eclampsia
on Aug 04, 2010 Female patient from INDIA , 20 years of age, weighting 141.1 lb, was diagnosed with prophylaxis against hiv infection (What is prophylaxis against hiv infection?), anaemia, pregnancy (What is pregnancy?) and was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: iron deficiency anaemia, oligohydramnios, postpartum haemorrhage, pre-eclampsia. Kaletra dosage: 200mg/50mg. During the same period patient was treated with FERROUS FUMARATE + VIT B12 + FOLIC ACID (0.3 Gram/15 Mcg/1.5 Mg) (View Ferrous Fumarate + Vit B12 + Folic Acid Review and Ferrous Fumarate + Vit B12 + Folic Acid Label ), ELEMENTAL CALCIUM + VITAMIN D3 (500mg/250mg) (View Elemental Calcium + Vitamin D3 Review and Elemental Calcium + Vitamin D3 Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), LAMIVUDINE + ZIDOVUDINE (300/150mg) (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ). Patient was hospitalized.

6928993-9 | Electrocardiogram Abnormal, Hypotension
Patient was taking Kaletra (View Usage). Patient had the following side effects: electrocardiogram abnormal, hypotension on Aug 07, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, . Kaletra dosage: Two 200/50-mg 2x Day. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DILTIAZEM CD (View Diltiazem Cd Review and Diltiazem Cd Label ). Patient was hospitalized.

6925622-5 | Escherichia Urinary Tract Infection, Pyelonephritis Acute
Adverse event was reported on Aug 06, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), lipoatrophy and. Location: SPAIN , weighting 111.8 lb, After Kaletra was administered, patient had the following side effects: escherichia urinary tract infection, pyelonephritis acute. Patient was hospitalized.

6924227-X | Atrioventricular Block Complete, Cardiomyopathy, Premature Baby
on Aug 05, 2010 Male patient from NETHERLANDS , weighting 2.39 lb, was diagnosed with prophylaxis against hiv infection (What is prophylaxis against hiv infection?) and was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block complete, cardiomyopathy (What is cardiomyopathy?), premature baby. Kaletra dosage: 460/115 Mg/m**2 Per Day. During the same period patient was treated with LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6924221-9 | Aphonia, Dyspnoea, Nausea
on Aug 05, 2010 Male patient from UNITED STATES , weighting 232.2 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient had the following side effects: aphonia, dyspnoea, nausea (What is nausea?). Kaletra dosage: .

6924116-0 | Aplasia Cutis Congenita, Congenital Anomaly, Umbilical Hernia
Patient was taking Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: aplasia cutis congenita, congenital anomaly, umbilical hernia on Aug 05, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 6.39 lb, . Kaletra dosage: . During the same period patient was treated with VIDEX (View Videx Review and Videx Label ), COMBIVIR (View Combivir Review and Combivir Label ), EPIVIR (View Epivir Review and Epivir Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

6922203-4 | Anal Cancer, Dermatitis, Pancytopenia, Papilloma Viral Infection
Adverse event was reported on Aug 05, 2010 by a Male patient taking Kaletra (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), diarrhoea and. Location: GERMANY , weighting 147.7 lb, Patient experienced the following unwanted or unexpected effects: anal cancer (What is anal cancer?), dermatitis, pancytopenia, papilloma viral infection. During the same period patient was treated with TRUVADA (200/245, Once Per Day) (View Truvada Review and Truvada Label ), IMODIUM (View Imodium Review and Imodium Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6922117-X | Abortion Induced
on Aug 06, 2010 Female patient from THAILAND , 17 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient had the following side effects: abortion induced. Kaletra dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), COMBIVIR (600/300mg Daily) (View Combivir Review and Combivir Label ), VIREAD (View Viread Review and Viread Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ).

6922020-5 | Hyperparathyroidism, Synovitis
on Aug 04, 2010 Male patient from UNITED KINGDOM , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: hyperparathyroidism, synovitis. Kaletra dosage: . During the same period patient was treated with ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), ABACAVIR SULFATE AND LAMIVUDINE (View Abacavir Sulfate And Lamivudine Review and Abacavir Sulfate And Lamivudine Label ).

6922017-5 | Anal Cancer, Anogenital Warts, Bronchitis, Leukopenia, Squamous Cell Carcinoma, Thrombocytopenia
Patient was taking Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: anal cancer (What is anal cancer?), anogenital warts, bronchitis (What is bronchitis?), leukopenia, squamous cell carcinoma, thrombocytopenia on Aug 02, 2010 from GERMANY Additional patient health information: Male patient , weighting 163.1 lb, was diagnosed with hiv infection (What is hiv infection?) and. Kaletra dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

6915112-8 | Acute Respiratory Failure, Bronchial Hyperreactivity, Chronic Obstructive Pulmonary Disease, Community Acquired Infection, Hyperchromic Anaemia, Hypoventilation, Microcytic Anaemia, Respiratory Tract Infection
Adverse event was reported on Jul 30, 2010 by a Female patient taking Kaletra (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), lipoatrophy, respiratory failure and. Location: SPAIN , weighting 126.8 lb, Patient had the following side effects: acute respiratory failure, bronchial hyperreactivity, chronic obstructive pulmonary disease, community acquired infection, hyperchromic anaemia, hypoventilation, microcytic anaemia, respiratory tract infection. During the same period patient was treated with SECALIP SUPRA (View Secalip Supra Review and Secalip Supra Label ), TRANXILIUM (View Tranxilium Review and Tranxilium Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), DEPRAX (View Deprax Review and Deprax Label ), ATARAX (View Atarax Review and Atarax Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), ABACAVIR SULFATE AND LAMIVUDINE (View Abacavir Sulfate And Lamivudine Review and Abacavir Sulfate And Lamivudine Label ). Patient was hospitalized.

6914342-9 | Congenital Cyst, Thyroglossal Cyst
on Jul 30, 2010 Female patient from UGANDA , weighting 8.01 lb, was treated with Kaletra (View Usage). After Kaletra was administered, patient had the following side effects: congenital cyst, thyroglossal cyst. Kaletra dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6913059-4 | Abdominal Pain Upper, Asthenia, Chills, Diarrhoea, Eczema, Hyponatraemia, Infection, Leukopenia, Lymphopenia
on Jul 28, 2010 Male patient from ISRAEL , weighting 116.8 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Kaletra (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, asthenia, chills, diarrhoea, eczema (What is eczema?), hyponatraemia, infection (What is infection?), leukopenia, lymphopenia. Kaletra dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RESPRIM FORTE (View Resprim Forte Review and Resprim Forte Label ). Patient was hospitalized.

6911214-0 | Aplasia Cutis Congenita, Umbilical Hernia
Patient was taking Kaletra (View Usage). Patient had the following side effects: aplasia cutis congenita, umbilical hernia on Jul 27, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 6.39 lb, . Kaletra dosage: . During the same period patient was treated with VIDEX (View Videx Review and Videx Label ), COMBIVIR (View Combivir Review and Combivir Label ), EPIVIR (View Epivir Review and Epivir Label ), VIRAMUNE (View Viramune Review and Viramune Label ).